Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab

Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab

Conditions: Diabetes Mellitus, Type 2; Osteoporosis
Interventions: Drug: Denosumab 60 mg/ml [Prolia]; Other: Placebo
Sponsors: Mishaela Rubin
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 4, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments